NASDAQ-listed clinical-stage biotech mining human aging data to discover metabolic and inflammatory-aging drugs.
Alphabet's aging-research company applying deep biology and drug discovery to age-related disease.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →